Network Meta-analysis of Chinese patent medicines in treatment of liver stagnation and spleen deficiency of depression.
10.19540/j.cnki.cjcmm.20190522.501
- Author:
Ying YU
1
;
Gong ZHANG
1
;
Tao HAN
1
;
Jie LI
1
;
Hai-Liang HUANG
1
Author Information
1. College of Traditional Chinese Medicine,Shandong University of Traditional Chinese Medicine Ji'nan 250355,China.
- Publication Type:Meta-Analysis
- Keywords:
Chinese patent medicine;
adjuvant therapy;
depression;
liver-stagnation and spleen-deficiency;
network Meta-analysis
- MeSH:
Depression/drug therapy*;
Drugs, Chinese Herbal/therapeutic use*;
Humans;
Liver/physiopathology*;
Medicine, Chinese Traditional;
Network Meta-Analysis;
Nonprescription Drugs/therapeutic use*;
Randomized Controlled Trials as Topic;
Spleen/physiopathology*
- From:
China Journal of Chinese Materia Medica
2019;44(23):5217-5224
- CountryChina
- Language:Chinese
-
Abstract:
To evaluate the clinical efficacy and safety of Shugan Jieyu Capsules,Jieyu Pills and Xiaoyao Pills in the treatment of liver-stagnation and spleen-deficiency depression by the network Meta-analysis( NMA),so as to provide evidence-based clinical practice. Chinese databases,including CNKI,VIP,Wan Fang Data,CBM as well as English databases including the Cochrane Library,PubMed,EMbase and Web of Science were retrieved from inception to October 30,2018,to collect randomized controlled trials( RCTs) about clinical study of the three kinds of Chinese patent medicines. The quality and bias risk of the included studies were assessed by 5. 1 standard in Cochrane Handbook,ADDIS software was applied in the statistical analysis,and the result were compared by NMA. A total of 37 studies involving 3 105 patients were included. The results of NMA showed that the adjuvant therapy with the three kinds of traditional Chinese patent medicines could improve the clinical efficacy. Jieyu Pills had the most significant effect( OR = 4. 59,95%CI[1. 94,12. 71],P<0. 05). In HAMD,Shugan Jieyu Capsules( MD = 3. 22,95%CI[2. 07,4. 39],P< 0. 05) and Xiaoyao Pills( MD= 2. 23,95%CI[0. 41,4. 03],P<0. 05) can effectively reduce the depression scale indicators. In the incidence of adverse reactions,the three kinds of Chinese patent medicines can reduce the incidence of adverse reactions. The three kinds of Chinese patent medicines can be combined with auxiliary Western medicine to treat liver-stagnation and spleen-deficiency depression,with complementary advantages in action mechanisms. In the clinical efficacy and safety,the Chinese patent medicines had good clinical manifestations. Although this study showed that Jieyu Pills may be the referred medicine for depression,this conclusion is still immature and needs to be further verified by high-quality RCTs studies,and the application shall be selective based on specific characteristics in clinic.
